Michael Parini Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Parini.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Michael Parini for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 216.26 | 354 | 76,556 | 30,837 | 31.2 K to 30.8 K (-1.13 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 214.28 | 680 | 145,710 | 31,191 | 31.9 K to 31.2 K (-2.13 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 213.04 | 1,348 | 287,178 | 31,871 | 33.2 K to 31.9 K (-4.06 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 211.58 | 646 | 136,681 | 33,219 | 33.9 K to 33.2 K (-1.91 %) |
| Feb 26 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Payment of Exercise | F | 217.57 | 2,416 | 525,649 | 33,865 | 36.3 K to 33.9 K (-6.66 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 213.45 | 200 | 42,690 | 36,281 | 36.5 K to 36.3 K (-0.55 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 212.56 | 1,952 | 414,917 | 36,481 | 38.4 K to 36.5 K (-5.08 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 211.83 | 4,666 | 988,399 | 38,433 | 43.1 K to 38.4 K (-10.83 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 210.08 | 1,007 | 211,551 | 43,099 | 44.1 K to 43.1 K (-2.28 %) |
| Feb 19 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Payment of Exercise | F | 211.75 | 6,240 | 1,321,320 | 44,106 | 50.3 K to 44.1 K (-12.39 %) |
| Feb 09 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 1,930 | 166,984 | 0 | |
| Feb 09 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 215.00 | 1,930 | 414,950 | 57,227 | 59.2 K to 57.2 K (-3.26 %) |
| Feb 09 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 1,930 | 166,984 | 59,157 | 57.2 K to 59.2 K (+3.37 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 400 | 34,608 | 1,930 | |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 218.20 | 100 | 21,820 | 57,227 | 57.3 K to 57.2 K (-0.17 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 217.00 | 100 | 21,700 | 57,327 | 57.4 K to 57.3 K (-0.17 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 215.52 | 200 | 43,104 | 57,427 | 57.6 K to 57.4 K (-0.35 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 400 | 34,608 | 57,627 | 57.2 K to 57.6 K (+0.70 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 11,627 | 0 | 57,227 | 45.6 K to 57.2 K (+25.50 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 10,324 | 0 | 45,600 | 35.3 K to 45.6 K (+29.27 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 8,438 | 0 | 35,276 | 26.8 K to 35.3 K (+31.44 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 400 | 34,608 | 1,930 | |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 218.20 | 100 | 21,820 | 57,227 | 57.3 K to 57.2 K (-0.17 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 217.00 | 100 | 21,700 | 57,327 | 57.4 K to 57.3 K (-0.17 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 215.52 | 200 | 43,104 | 57,427 | 57.6 K to 57.4 K (-0.35 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 400 | 34,608 | 57,627 | 57.2 K to 57.6 K (+0.70 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 11,627 | 0 | 57,227 | 45.6 K to 57.2 K (+25.50 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 10,324 | 0 | 45,600 | 35.3 K to 45.6 K (+29.27 %) |
| Feb 05 2021 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Grant | A | 0.00 | 8,438 | 0 | 35,276 | 26.8 K to 35.3 K (+31.44 %) |